Several studies have reported that DNA methylation levels at obesity-associated CpG sites were associated with cardio-metabolic factors such as lipids, insulin resistance, and blood pressure [26, 64]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.